Cardiovascular and InflammAging Study
Effects of Long-term Consumption of Two Plant-based Dietary Supplements on Cardiovascular Health and Low-grade Inflammation in the Elderly
1 other identifier
interventional
80
1 country
2
Brief Summary
Evidence from previous studies supports a strong relationship between fruit and vegetable consumption and reduced cardiac risk. This could be mediated via improvements on blood pressure, platelet function and vascular reactivity. Certain vitamins and polyphenols found in fruits and vegetables, have antioxidant and anti-inflammatory effects and play a major role on the function of immune cells. Previous studies have also demonstrated the importance of omega-3 fatty acids on humans' health and their positive effects on the cardiovascular system and blood lipids regulation, as well as their involvement on inflammatory response. Nutritional regimens with adequate intake of micronutrients, fruit and vegetables, omega-3 fatty acids, low in sugar and saturated fats, such as the Mediterranean diet or vegetarian diets, can reduce chronic inflammation and oxidative stress and improve cardiovascular risk profile. Considering that the population's fruit and vegetable and omega-3 intakes are below recommendations, whole food-based supplements could provide an accessible form of supplementation to bridge the gap between actual and recommended intakes. This study is aiming to assess whether long-term separate ingestions of an encapsulated juice powder concentrate and a plant-based omega fatty acid supplement, or a combined ingestion of the two, can affect biomarkers of cardiovascular health, low-grade inflammation and indicators of biological aging in older adults.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Sep 2021
Longer than P75 for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 2, 2021
CompletedFirst Posted
Study publicly available on registry
February 21, 2021
CompletedStudy Start
First participant enrolled
September 1, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2026
ExpectedJuly 1, 2025
June 1, 2025
4.7 years
February 2, 2021
June 30, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (5)
Lipid profile markers
Total cholesterol, HDL, LDL, ApoA1, triglycerides, Omega-3-Index
12 months
Hemostasis markers
Platelet aggregation, thrombelastometry, coagulation (Quick, PT, PTT)
12 months
Oxidative stress markers
oxLDL, MDA, carbonyl proteins, (CP), redox state of albumin, homocysteine
12 months
Glucose metabolism
Glucose, insulin, HOMA-IR, HbA1c
12 months
Concentration changes in cytokines/ cytokine receptors
TNF-α, sTNFR1 and sTNFR2, CCL5 = RANTES, IL-1β, hsCRP, CCL2 = MCP-1, Osteoprotegerin (OPG), IL-5, IL-8
12 months
Secondary Outcomes (6)
Vitamin K metabolism
12 months
mitochondrial DNA copy number (mtDNA-CN)
12 months
Upper respiratory tract symptoms
12 months
Quality of life Questionnaire
12 months
Cognitive function
12 months
- +1 more secondary outcomes
Other Outcomes (2)
Plasma concentrations of vitamins and carotenoids
12 months
Plasma concentrations of fatty acids
12 months
Study Arms (4)
Control group
NO INTERVENTIONContinue habitual diet and lifestyle.
Fruit, Vegetable and Berry (FVB) group
EXPERIMENTALParticipants have to ingest an encapsulated juice powder concentrate, otherwise continue their habitual diet and lifestyle.
Omega group
EXPERIMENTALParticipants have to ingest a plant-based fatty acid supplement, otherwise continue their habitual diet and lifestyle.
Fruit, Vegetable, Berry and Omega (FVBO) group
EXPERIMENTALParticipants have to ingest an encapsulated juice powder concentrate along with a plant-based fatty acid supplement, otherwise continue their habitual diet and lifestyle.
Interventions
Encapsulated juice powder concentrate derived from 36 dried fruits, vegetables and berries.
Encapsulated plant-based fatty acid supplement.
Eligibility Criteria
You may qualify if:
- Post menopausal
- Non-smokers
- BMI 18.5 to 40 kg/m2
- Vegetable intake ≤ 2 servings/ day
- Intake of fruits ≤ 2 servings /day
- Adherence to a 6-week washout period for dietary supplements not ingested for specific medical conditions.
You may not qualify if:
- Age \<55 and \>80 years
- Smokers (or ex-smokers who quit smoking less than 3 years ago)
- Aversion to stop the intake of multivitamins, multiminerals or omega fatty acid supplements
- Subjects with histamine intolerance
- Hypertension, starting with grade 2 according to the classification of the European Society of Hypertension: systolic blood pressure \> 160mmHg, diastolic blood pressure \>100 mmHg
- All medication taken for less than 3 months or with changes on the dosage over the last 3 months and medication for any of the conditions listed below.
- Clinically relevant infectious diseases
- Diabetes mellitus type I and type II
- Rheumatic diseases
- Auto-immune diseases
- Any stents and coronary artery diseases (CAD)
- Cancer patients
- Pregnancy
- Significant lifestyle changes, e.g. changes in diet or physical activity profile
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Green Beatlead
- Medical University of Grazcollaborator
Study Sites (2)
Green Beat
Graz, 8042, Austria
Otto Loewi Research Center, Section of Physiological Chemistry, Medical University of Graz
Graz, Austria
Related Publications (1)
Tsiountsioura M, Cvirn G, Meixner-Goetz L, Ziegler T, Lamprecht M. Effects of long-term consumption of two plant-based dietary supplements on cardiovascular health and low-grade inflammation in middle-aged and elderly people: study protocol for a randomised, controlled trial. J Health Popul Nutr. 2023 Sep 19;42(1):100. doi: 10.1186/s41043-023-00434-x.
PMID: 37726820DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Manfred Lamprecht, PhD
Green Beat
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
February 2, 2021
First Posted
February 21, 2021
Study Start
September 1, 2021
Primary Completion
May 1, 2026
Study Completion (Estimated)
December 1, 2026
Last Updated
July 1, 2025
Record last verified: 2025-06
Data Sharing
- IPD Sharing
- Will not share